Simon Pimstone
CEO
Board Member
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Xenon Pharmaceuticals Inc. (XENE) | Executive Chair of the Board | $525,511 | $4,116,416 |
| 2020 | Xenon Pharmaceuticals Inc. (XENE) | Executive Chair of the Board | $498,117 | $2,941,911 |
| 2019 | Xenon Pharmaceuticals Inc. (XENE) | Executive Chair of the Board | $445,688 | $2,612,720 |
| 2018 | Xenon Pharmaceuticals Inc. (XENE) | Chief Executive Officer | $400,555 | $1,165,195 |
| 2017 | Xenon Pharmaceuticals Inc. (XENE) | Chief Executive Officer | $399,052 | $1,469,198 |
Executive changes
Earnings-call appearances
-
Xenon Pharmaceuticals Inc. Q2 FY2021 Earnings Call2021-08-11
Xenon Pharmaceuticals Inc. (XENE)
-
Xenon Pharmaceuticals Inc. Q1 FY2021 Earnings Call2021-05-11
Xenon Pharmaceuticals Inc. (XENE)
-
Xenon Pharmaceuticals Inc. Q4 FY2020 Earnings Call2021-03-01
Xenon Pharmaceuticals Inc. (XENE)
-
Xenon Pharmaceuticals Inc. Q3 FY2020 Earnings Call2020-11-05
Xenon Pharmaceuticals Inc. (XENE)
-
Xenon Pharmaceuticals Inc. Q2 FY2020 Earnings Call2020-08-06
Xenon Pharmaceuticals Inc. (XENE)
-
Xenon Pharmaceuticals Inc. Q1 FY2020 Earnings Call2020-05-21
Xenon Pharmaceuticals Inc. (XENE)